Molecular Pathology 2003;56:59
© 2003 BMJ Publishing Group & Association of Clinical Pathologists
Housekeeping genes confound mRNA assays in asthma
| The first 150 words of the full text of this article appear below. |
A n Australian study is the first to question routine use in asthma research of two genes widely used for standardising quantitative mRNA assays. The expression of ß actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) needs careful validation first, say the researchers.
They used a reverse transcriptase (RT)-PCR method that does not rely on internal standards to measure ß actin and GAPDH mRNA in bronchiolar lavage (BAL) fluid cells and bronchial biopsy samples from 92 asthmatic and 26 normal control volunteers.
Correlation coefficients for amounts of ß actin and GAPDH mRNA indicated that expression was not comparable at the resolution of the method. GAPDH mRNA varied among biopsy samples and was about five times lower in BAL fluid cells than ß actin mRNA. Furthermore, asthmatic subjects showed lower ß actin and GAPDH expression overall, but not using inhaled corticosteroids resulted in tenfold lower GAPDH than in the controls and subjects who did. . . . [Full text of this article]
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.